BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:04 PM
 | 
Jul 28, 2009
 |  BC Extra  |  Clinical News

Ariad gains on ridaforolimus data

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) gained $0.35 (14%) to $2.80 on 22.5 million shares on Tuesday after reporting data from two trials of ridaforolimus. Preliminary data from 28 evaluable patients...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >